company background image
PNV

PolyNovo ASX:PNV Stock Report

Last Price

AU$2.39

Market Cap

AU$1.6b

7D

-5.5%

1Y

82.4%

Updated

27 Jan, 2023

Data

Company Financials +

PNV Stock Overview

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally.

PNV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth6/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

PolyNovo Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PolyNovo
Historical stock prices
Current Share PriceAU$2.39
52 Week HighAU$2.65
52 Week LowAU$0.83
Beta1.42
1 Month Change21.01%
3 Month Change22.25%
1 Year Change82.44%
3 Year Change-14.64%
5 Year Change359.62%
Change since IPO1,095.00%

Recent News & Updates

Returns At PolyNovo (ASX:PNV) Are On The Way Up

Nov 16
Returns At PolyNovo (ASX:PNV) Are On The Way Up

PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

Recent updates

Returns At PolyNovo (ASX:PNV) Are On The Way Up

Nov 16
Returns At PolyNovo (ASX:PNV) Are On The Way Up

PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

Jul 29
What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Jun 15
PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

May 16
Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

Apr 28
We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Mar 07
There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

Dec 13
Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 19
PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

May 08
Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Feb 27
News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Feb 25
Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

Feb 17
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

These Analysts Think PolyNovo Limited's (ASX:PNV) Earnings Are Under Threat

Jan 14
These Analysts Think PolyNovo Limited's (ASX:PNV) Earnings Are Under Threat

Breakeven Is Near for PolyNovo Limited (ASX:PNV)

Dec 28
Breakeven Is Near for PolyNovo Limited (ASX:PNV)

Shareholder Returns

PNVAU Medical EquipmentAU Market
7D-5.5%-2.4%0.6%
1Y82.4%2.2%3.5%

Return vs Industry: PNV exceeded the Australian Medical Equipment industry which returned 2.2% over the past year.

Return vs Market: PNV exceeded the Australian Market which returned 3.5% over the past year.

Price Volatility

Is PNV's price volatile compared to industry and market?
PNV volatility
PNV Average Weekly Movement7.5%
Medical Equipment Industry Average Movement10.3%
Market Average Movement8.6%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: PNV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: PNV's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998152Swami Raotehttps://polynovo.com

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots.

PolyNovo Limited Fundamentals Summary

How do PolyNovo's earnings and revenue compare to its market cap?
PNV fundamental statistics
Market CapAU$1.64b
Earnings (TTM)-AU$1.19m
Revenue (TTM)AU$41.89m

39.3x

P/S Ratio

-1,379x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PNV income statement (TTM)
RevenueAU$41.89m
Cost of RevenueAU$7.95m
Gross ProfitAU$33.94m
Other ExpensesAU$35.13m
Earnings-AU$1.19m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0017
Gross Margin81.02%
Net Profit Margin-2.85%
Debt/Equity Ratio23.3%

How did PNV perform over the long term?

See historical performance and comparison